fda compounding semaglutide crackdown 2025 news The growing availability of compounded GLP-1 weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. Link in comments⬇️ FDA is cracking down on

The Protein Problem This is the other side of the equation and it hits women over 40 especially hard

Trypsin with two miscleavages allowed was used

It's not clear whether OrderlyMeds' approach will work, but the telehealth platform is one of several companies testing the FDA's rules by continuing to make and sell the compounded drugs

Hims' GLP-1 drugs start at $199 a month, while Wegovy and Ozempic cost over $900 a month though the price many patients pay depends on their insurance

A heads up on the evidence

Even in preliminary studies, retatrutide users can drop an impressive amount of weight sometimes more than 20% of their initial body weight